Company / Free Cash Flow per Share
Atea Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.48
FY2022
5-year range
-$1.48 / -$0.16
FY2020-FY2022
Trend
-850.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -850% YoY in FY2022, a notable deviation from the 2-year average annual change of -385%.
Based on SEC 10-K filings.
-1.48 in FY2022.
Declined from $-0.78 to $-1.48 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, free cash flow per share decreased 850.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$1.48 | -850.4% |
| FY2021 | -$0.16 | +80.2% |
| FY2020 | -$0.78 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026